Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will release results for its third quarter ended Sept. 30, 2024, after the market closes on Nov. 12, 2024. Natera will host a conference call and webcast shortly thereafter at 1:30 p.m. PT (4:30 p.m. ET).

Earnings Conference Call Information:

Event:                     

Natera’s Third Quarter 2024 Financial Results

Date:                      

Tuesday, Nov. 12, 2024

Time:                      

1:30 p.m. PT (4:30 p.m. ET)

Live Dial-In:           

1-888-770-7321 (Domestic)

 

1-929-201-7107 (International)

Conference ID:      

7684785

Webcast:                  

https://events.q4inc.com/attendee/883846048

A webcast replay will be available at investor.natera.com.

About Natera

Natera™ is a global leader in cell-free DNA and genetic testing, dedicated to oncology, women’s health, and organ health. We aim to make personalized genetic testing and diagnostics part of the standard of care to protect health, and inform earlier, more targeted interventions that help lead to longer, healthier lives. Natera’s tests are validated by more than 200 peer-reviewed publications that demonstrate high accuracy. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. For more information, visit www.natera.com.

Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com

Grafico Azioni Natera (NASDAQ:NTRA)
Storico
Da Mar 2025 a Mar 2025 Clicca qui per i Grafici di Natera
Grafico Azioni Natera (NASDAQ:NTRA)
Storico
Da Mar 2024 a Mar 2025 Clicca qui per i Grafici di Natera